Company profile for Ischemix

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Ischemix is a privately-held pharmaceutical company that is developing novel cytoprotective compounds for serious neurological diseases and conditions. Proof of concept in two preclinical models (focal and diffuse) of TBI. Significant improvement vs controls in sensorimotor and cognitive endpoints of learning and memory. Proof of concept in two types of test subjects in a preclinical model of TBI. Significant reduction in br...
Ischemix is a privately-held pharmaceutical company that is developing novel cytoprotective compounds for serious neurological diseases and conditions. Proof of concept in two preclinical models (focal and diffuse) of TBI. Significant improvement vs controls in sensorimotor and cognitive endpoints of learning and memory. Proof of concept in two types of test subjects in a preclinical model of TBI. Significant reduction in brain lesion size, improvement in levels of brain metabolites, upregulation of mitochondrial energetics and reduction of reactive oxygen species in treated subjects versus controls.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
13 Pullard Road Grafton, MA 01519
Telephone
Telephone
508 839 2999
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

BPI Europe

BPI Europe

Not Confirmed

envelop Contact Supplier

BPI Europe

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty